Project Grant R21OH012960

Federal Project Grant Summary Icahn School of Medicine at Mount Sinai received a $809,307 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective July 1, 2026 through March 31, 2031. The award supports the "Am I At Risk? Health Empowerment Through Population Genomic Screening for Transthyretin Amyloidosis" initiative, which will deliver population-based genomic screening services and...

Federal Project Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded $123,368 to The Research Foundation for the State University of New York (SUNY ESF) on September 16, 2025, under the Cardiovascular Diseases Research program (CFDA 93.837). This K01 career development award, which extends through August 31, 2030, supports research examining the effects of structural racism on cardiovascular disease (CVD) disparities in underserved populations. The project...

Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded The University of Texas Southwestern Medical Center a $1.62 million Project Grant on September 25, 2025, under the Cardiovascular Diseases Research program (CFDA 93.837) to investigate circulating metabolites underlying cardiometabolic risk for cardiac dysfunction and heart failure in diverse populations. The research employs metabolomics and genomics to identify biologic pathways linking metabolic...

Albert Einstein College of Medicine received a $1,123,325 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) effective September 11, 2025, with completion scheduled for June 30, 2030. The research initiative will investigate the relationship between environmental exposure to pollutants—including polycyclic aromatic hydrocarbons from industrial pollution,...

Grant Award Summary Albany Medical College received a $586,474 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded June 15, 2026, with completion targeted for February 28, 2030. The funded research addresses lipolytic sterol signaling mechanisms to promote favorable foam cell modulation and atherosclerosis protection. The project investigates how lipid droplet-associated hydrolase (LDAH) mobilizes...

Federal Project Grant Award Summary The University of Alabama at Birmingham received a $735,327 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded June 22, 2026, with completion targeted for March 31, 2030. This award funds research to identify individual and contextual risk factors for chronic limb-threatening ischemia (CLTI), a severe form of peripheral artery disease (PAD) that accounts for the...

Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded Rutgers The State University of New Jersey a $721,720 Project Grant effective September 1, 2025, through July 31, 2029, under the Cardiovascular Diseases Research program (CFDA 93.837). This research initiative investigates the psychosocial and cultural determinants of cardiometabolic health among older foreign-born Chinese Americans, an understudied population disproportionately affected by...

Grant Award Summary Rutgers The State University of New Jersey, School of Nursing, received a $117,750 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective May 1, 2026, with completion targeted for February 28, 2028. The award funds a research study titled "Proteomic Profiling and Neurocognitive Assessment to Uncover Stroke Mechanisms in Adults with Sickle Cell Disease," which...

Federal Project Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded Icahn School of Medicine at Mount Sinai $856,812 on June 22, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to conduct a genome-wide association study (GWAS) investigating the genetic mechanisms that distinguish obesity from cardiometabolic disease risk. The research integrates data from large multi-ancestry cohorts to identify genes and pathways underlying the...

Federal Project Grant Award Summary New York University School of Medicine received a $254,250 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded September 15, 2025, with completion targeted for August 30, 2027. This research project examines neighborhood context factors and their influence on sleep health disparities among first and second-grade children, primarily Black students in New York City....